Ultralife (NASDAQ:ULBI) Downgraded by StockNews.com

StockNews.com cut shares of Ultralife (NASDAQ:ULBIFree Report) from a strong-buy rating to a buy rating in a research report report published on Tuesday morning.

Separately, Benchmark upped their price objective on Ultralife from $12.00 to $13.00 and gave the stock a buy rating in a research note on Tuesday, March 5th.

View Our Latest Report on ULBI

Ultralife Stock Performance

Shares of ULBI stock opened at $8.81 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.02 and a current ratio of 3.80. Ultralife has a fifty-two week low of $3.86 and a fifty-two week high of $11.85. The stock has a 50 day moving average price of $8.45 and a two-hundred day moving average price of $8.32. The company has a market capitalization of $144.92 million, a P/E ratio of 20.02 and a beta of 1.26.

Ultralife (NASDAQ:ULBIGet Free Report) last released its earnings results on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. Ultralife had a return on equity of 7.36% and a net margin of 4.54%. The firm had revenue of $44.55 million for the quarter.

Institutional Trading of Ultralife

A number of institutional investors and hedge funds have recently made changes to their positions in ULBI. Acadian Asset Management LLC acquired a new stake in shares of Ultralife during the third quarter valued at about $1,039,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Ultralife during the third quarter valued at approximately $36,000. Jump Financial LLC acquired a new position in shares of Ultralife during the third quarter valued at approximately $118,000. ClariVest Asset Management LLC acquired a new position in Ultralife in the third quarter worth approximately $616,000. Finally, Barclays PLC acquired a new position in Ultralife in the third quarter worth approximately $127,000. 30.68% of the stock is currently owned by institutional investors and hedge funds.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.